GenScript Biotech Corporation (HK:1548), a China-based global provider of life science research and manufacturing services, announced on Wednesday that it has been awarded a Silver Medal by EcoVadis, a business sustainability assessment platform.
This recognition marks the company's significant progress in the areas of environment, labour and human rights, ethics, and sustainable procurement. The award places GenScript in the top 15% of all companies assessed by EcoVadis worldwide.
In the latest reassessment, GenScript outperformed 85% of companies globally and was in the top 10% in the sector of manufacture of basic pharmaceutical products and pharmaceutical preparations.
REGENXBIO reports RGX-202 preclinical results in Duchenne Muscular Dystrophy
MetaVia doses first patient in 48 mg MAD cohort of DA-1726 Phase 1 trial
Zhimeng Biopharma's CB03-154 ALS Phase 2/3 study receives Chinese clinical trial approval
Taiho Oncology and Taiho Pharmaceutical's INQOVI/venetoclax combination sNDA accepted by US FDA
SciBase introduces Nevisense pilot at Florida research university
Tyra Biosciences to announce TYRA-300 preclinical results at ENDO 2025
Centivax raises USD45m to commercialise universal flu vaccine
Adcentrx Therapeutics' ADRX-0405 granted US FDA orphan drug designation
Avenzo Therapeutics doses first patient in AVZO-1418/DB-1418 Phase 1/2 clinical study
SCG Cell's SCG101V therapy Investigational New Drug Application receives Chinese regulatory approval
KalVista secures FDA approval for EKTERLY, first oral on-demand HAE treatment
BioDlink convenes peer advisory event on innovation and collaboration strategies